FI55998B - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-alkylamino-dihydropyridiner - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-alkylamino-dihydropyridiner

Info

Publication number
FI55998B
FI55998B FI2517/73A FI251773A FI55998B FI 55998 B FI55998 B FI 55998B FI 2517/73 A FI2517/73 A FI 2517/73A FI 251773 A FI251773 A FI 251773A FI 55998 B FI55998 B FI 55998B
Authority
FI
Finland
Prior art keywords
therapeutic
dihydropyridine
alkylamino
preparation
frame
Prior art date
Application number
FI2517/73A
Other languages
English (en)
Other versions
FI55998C (fi
Inventor
Horst Meyer
Friedrich Bossert
Wulf Vater
Kurt Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI55998B publication Critical patent/FI55998B/fi
Application granted granted Critical
Publication of FI55998C publication Critical patent/FI55998C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI2517/73A 1972-08-12 1973-08-10 Foerfarande foer framstaellning av nya tarapeutiskt anvaendbara 2-alkylaminodihydropyridiner FI55998C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2239815A DE2239815C2 (de) 1972-08-12 1972-08-12 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
FI55998B true FI55998B (fi) 1979-07-31
FI55998C FI55998C (fi) 1979-11-12

Family

ID=5853453

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2517/73A FI55998C (fi) 1972-08-12 1973-08-10 Foerfarande foer framstaellning av nya tarapeutiskt anvaendbara 2-alkylaminodihydropyridiner

Country Status (29)

Country Link
US (1) US3959292A (fi)
JP (1) JPS5626660B2 (fi)
KR (1) KR780000072B1 (fi)
AT (1) AT327194B (fi)
AU (1) AU469267B2 (fi)
BE (1) BE803474A (fi)
BG (1) BG22816A3 (fi)
CA (1) CA1016945A (fi)
CH (1) CH583196A5 (fi)
CS (1) CS178892B2 (fi)
DD (1) DD109627A5 (fi)
DE (1) DE2239815C2 (fi)
DK (1) DK136062C (fi)
ES (1) ES417807A1 (fi)
FI (1) FI55998C (fi)
FR (1) FR2195450B1 (fi)
GB (1) GB1384219A (fi)
HU (1) HU167991B (fi)
IE (1) IE37989B1 (fi)
IL (1) IL42933A (fi)
LU (1) LU68206A1 (fi)
NL (1) NL7311031A (fi)
NO (1) NO139130C (fi)
PL (1) PL89396B1 (fi)
RO (1) RO62914A (fi)
SE (1) SE386164B (fi)
SU (1) SU475772A3 (fi)
YU (1) YU36172B (fi)
ZA (1) ZA735460B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2639257A1 (de) * 1976-09-01 1978-03-02 Bayer Ag Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4442100A (en) * 1979-12-11 1984-04-10 Bayer Aktiengesellschaft Substituted 2-amino-3,4-dihydropyridine derivatives, their production and their medicinal use
DE3134945A1 (de) * 1981-09-03 1983-03-17 Bayer Ag, 5090 Leverkusen Substituierte 2-amino-3,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimittel
ATE50987T1 (de) * 1982-05-10 1990-03-15 Takeda Chemical Industries Ltd Dihydropyridinderivate, deren herstellung und verwendung.
US4603135A (en) * 1983-10-17 1986-07-29 Takeda Chemical Industries, Ltd. Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates
US4678796A (en) * 1984-11-30 1987-07-07 Warner-Lambert Company 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyridine carboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
FI862343A (fi) 1985-06-17 1986-12-18 Warner Lambert Co Foerfarande foer framstaellning av terapeutiskt verkande 1,4-dihydropyridinfoereningar.
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
SE8701172D0 (sv) * 1987-03-20 1987-03-20 Sandvik Ab Whiskerforsterkt keramiskt skerverktyg
CN111491769B (zh) 2017-12-22 2022-07-22 东丽株式会社 带状预浸料及其制造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester

Also Published As

Publication number Publication date
FR2195450B1 (fi) 1977-09-09
ES417807A1 (es) 1976-03-01
PL89396B1 (fi) 1976-11-30
BE803474A (fr) 1974-02-11
ATA707073A (de) 1975-04-15
ZA735460B (en) 1974-07-31
IE37989B1 (en) 1977-11-23
GB1384219A (en) 1975-02-19
LU68206A1 (fi) 1973-10-16
SU475772A3 (ru) 1975-06-30
SE386164B (sv) 1976-08-02
JPS5626660B2 (fi) 1981-06-19
KR780000072B1 (en) 1978-03-30
FR2195450A1 (fi) 1974-03-08
YU36172B (en) 1982-02-25
IL42933A (en) 1977-04-29
YU213373A (en) 1981-06-30
HU167991B (fi) 1976-02-28
RO62914A (fr) 1977-11-15
NL7311031A (fi) 1974-02-14
NO139130C (no) 1979-01-10
US3959292A (en) 1976-05-25
CA1016945A (en) 1977-09-06
CS178892B2 (en) 1977-10-31
DK136062B (da) 1977-08-08
NO139130B (no) 1978-10-02
AT327194B (de) 1976-01-26
CH583196A5 (fi) 1976-12-31
DD109627A5 (fi) 1974-11-12
DE2239815C2 (de) 1983-02-10
AU469267B2 (en) 1976-02-05
AU5912473A (en) 1975-02-13
DE2239815A1 (de) 1974-02-21
JPS4945079A (fi) 1974-04-27
FI55998C (fi) 1979-11-12
IE37989L (en) 1974-02-12
DK136062C (da) 1978-01-09
IL42933A0 (en) 1973-11-28
BG22816A3 (bg) 1977-04-20

Similar Documents

Publication Publication Date Title
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
FI54301B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat
SE386445B (sv) Forfaranden for framstellning av nya bensotiadiazoler
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE382053B (sv) Forfarande for framstellning av bifenylylalkanoylaminopyridiner
SE383151B (sv) Forfarande for framstellning av 1-hydroxi-2-pyridoner
FI55998B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-alkylamino-dihydropyridiner
SE414025B (sv) Forfarande for framstellning av fototropa flerfokala glasogonglas
FI54602C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 6-amidinopenicillansyraderivat
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
NO136750C (no) Fremgangsm}te for fremstilling av indanderivater
SE384027B (sv) Forfarande for framstellning av nya alfa-alkylsulfobensylpenicilliner
SE389862B (sv) Forfarande for framstellning av alfa-6-deoxitetracykliner
NO139086C (no) R fremgangsmaate for fremstilling av benzensulfonylurinstoffe
SE404361B (sv) Forfarande for framstellning av nya 1-fenyl-3hydroxi-3-metyl-triazener
SE396377B (sv) Forfarande for framstellning av difenylmetoxietylaminer
SE386673B (sv) Forfarande for framstellning av 2-amino-2-oxazoliner
SE408643B (sv) Forfarande for framstellning av morfantridiner